BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16329563)

  • 1. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
    Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
    Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular markers in acute myeloid leukemia diagnosis.
    Koníková E; Glasová M; Kusenda J; Babusíková O
    Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
    Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
    Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
    Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of myeloperoxidase activity in primary leukemic cells by an enhanced chemiluminescent assay for differentiation between acute lymphoblastic and non-lymphoblastic leukemia.
    Tan S; Wang G; Peng M; Zhang X; Shen G; Jiang J; Chen F
    Clin Chim Acta; 2009 May; 403(1-2):216-8. PubMed ID: 19298796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
    Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
    Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
    Knapp W; Strobl H; Majdic O
    Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry is a more sensitive marker for the detection of myeloperoxidase in acute myeloid leukemia compared with flow cytometry and cytochemistry.
    Saravanan L; Juneja S
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e132-6. PubMed ID: 19077157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of cytoplasmic antigens in acute leukemia by flow cytometry].
    Kawai S; Zha Z; Yamamoto Y; Nakadate H; Kawakami K; Kikuta A; Utsumi J; Nishikawa K; Mimaya J; Miyake M
    Rinsho Ketsueki; 1993 Jan; 34(1):13-20. PubMed ID: 8450602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia, FAB M-1 microgranular variant: a multiparameter study.
    Nguyen D; Brynes RK; Macaulay L; Kaplan B; Pinter-Brown LC
    Hematol Pathol; 1989; 3(1):11-22. PubMed ID: 2545666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.
    Storr J; Dolan G; Coustan-Smith E; Barnett D; Reilly JT
    J Clin Pathol; 1990 Oct; 43(10):847-9. PubMed ID: 1977771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lymphoblastic leukemia with myeloperoxidase activity.
    Wright S; Chucrallah A; Chong YY; Kantarjian H; Keating M; Albitar M
    Am J Hematol; 1996 Feb; 51(2):147-51. PubMed ID: 8579056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7.
    Hirai K; Torimoto Y; Moriichi K; Sato K; Ohnishi K; Taya N; Kohgo Y
    Int J Hematol; 1999 Jul; 70(1):30-5. PubMed ID: 10446492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry.
    Buccheri V; Shetty V; Yoshida N; Morilla R; Matutes E; Catovsky D
    Br J Haematol; 1992 Jan; 80(1):62-8. PubMed ID: 1311196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal antibodies in diagnosis of acute leukemias].
    Krawczyńska A; Robak T
    Przegl Lek; 1996; 53(1):20-5. PubMed ID: 8711170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal.
    Kaleem Z; White G
    Am J Clin Pathol; 2001 Jun; 115(6):876-84. PubMed ID: 11392885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of immunocytochemical detection of myeloperoxidase in undifferentiated and biphenotypic acute leukemias.
    Musto P; Cascavilla N; Melillo L; Matera R; Carotenuto M
    Haematologica; 1991; 76(5):434-6. PubMed ID: 1666891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia.
    Guy J; Antony-Debré I; Benayoun E; Arnoux I; Fossat C; Le Garff-Tavernier M; Raimbault A; Imbert M; Maynadié M; Lacombe F; Béné MC; Wagner-Ballon O;
    Br J Haematol; 2013 May; 161(4):551-5. PubMed ID: 23432206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.